Abstract
Background/Objectives:
Reduced food intake, appetite loss and alteration of ghrelin and PYY3−36 secretion have been suggested to have a function in the loss of body weight commonly observed after gastrectomy. The objective of this study was to investigate the circulating concentrations of ghrelin and PYY3−36 and their relationships with food intake, appetite and resting energy expenditure (REE) after gastrectomy plus vagotomy.
Subjects/Methods:
Seven patients with total gastrectomy (TG), 14 with partial gastrectomy (PG) and 10 healthy controls were studied. Habitual food intake and REE was assessed; fasting and postprandial plasma total ghrelin, PYY3−36 concentrations and appetite ratings were determined after ingestion of a liquid test meal.
Results:
Differently from PG and controls, fasting ghrelin correlated with REE, and a higher energy intake was observed in the TG group. Fasting plasma ghrelin concentrations were lower in TG compared with controls, and no ghrelin response to the meal was observed in either PG or TG. Fasting plasma PYY3−36 concentrations were not different among the groups. There was an early and exaggerated postprandial rise in PYY3−36 levels in both PG and TG groups, but not in controls. No effect of ghrelin or PYY3−36 concentrations was observed on hunger, prospective consumption or fullness ratings.
Conclusions:
Total ghrelin and PYY3−36 do not seem to be involved with appetite or energy intake regulation after gastrectomy plus vagotomy. Ghrelin secreted by sources other than stomach is likely to have a function in the long-term regulation of body weight after TG.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JR et al. (2005). The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044, 127–131.
Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T et al. (2001). Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86, 4753–4758.
Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS et al. (2003). Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349, 941–948.
Bergh C, Sjostedt S, Hellers G, Zandian M, Sodersten P (2003). Meal size, satiety and cholecystokinin in gastrectomized humans. Physiol Behav 78, 143–147.
Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG (2007). Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg 17, 1193–1198.
Chan JL, Mun EC, Stoyneva V, Mantzoros CS, Goldfine AB (2006). Peptide YY levels are elevated after gastric bypass surgery. Obesity (Silver Spring) 14, 194–198.
Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS (2001). A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714–1719.
Da Rocha EE, Alves VG, da Fonseca RB (2006). Indirect calorimetry: methodology, instruments and clinical application. Curr Opin Clin Nutr Metab Care 9, 247–256.
Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T et al. (2000). Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141, 4255–4261.
De Smet B, Depoortere I, Moechars D, Swennen Q, Moreaux B, Cryns K et al. (2006). Energy homeostasis and gastric emptying in ghrelin knockout mice. J Pharmacol Exp Ther 316, 431–439.
Degen L, Oesch S, Casanova M, Graf S, Ketterer S, Drewe J et al. (2005). Effect of Peptide YY(3-36) on food intake in humans. Gastroenterology 129, 1430–1436.
Di Francesco V, Zamboni M, Zoico E, Mazzali G, Dioli A, Omizzolo F et al. (2006). Unbalanced serum leptin and ghrelin dynamics prolong postprandial satiety and inhibit hunger in healthy elderly: another reason for the ‘anorexia of aging’. Am J Clin Nutr 83, 1149–1152.
Flint A, Raben A, Blundell JE, Astrup A (2000). Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 24, 38–48.
Frecka JM, Mattes RD (2008). Possible entrainment of ghrelin to habitual meal patterns in humans. Am J Physiol Gastrointest Liver Physiol 294, 699–707.
Hosoda H, Kangawa K (2008). The autonomic nervous system regulates gastric ghrelin secretion in rats. Regul Pept 146, 12–18.
Hosoda H, Kojima M, Kangawa K (2006). Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci 100, 398–410.
Jeon TY, Lee S, Kim HH, Kim YJ, Son HC, Kim DH et al. (2004). Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab 89, 5392–5396.
Kamiji MM, Troncon LE, Suen VM, de Oliveira RB (2009). Gastrointestinal transit, appetite, and energy balance in gastrectomized patients. Am J Clin Nutr 89, 231–239.
Katai H, Sano T, Fukagawa T, Shinohara H, Sasako M (2003). Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach. Br J Surg 90, 850–853.
Koda S, Date Y, Murakami N, Shimbara T, Hanada T, Toshinai K et al. (2005). The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 146, 2369–2375.
Lavin JH, French SJ, Ruxton CH, Read NW (2002). An investigation of the role of oro-sensory stimulation in sugar satiety? Int J Obes Relat Metab Disord 26, 384–388.
Le Roux C, Neary NM, Halsey TJ, Small CJ, Martinez-Isla AM, Ghatei MA et al. (2005). Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 90, 4521–4524.
Liedman B, Svedlund J, Sullivan M, Larsson L, Lundell L (2001). Symptom control may improve food intake, body composition, and aspects of quality of life after gastrectomy in cancer patients. Dig Dis Sci 46, 2673–2680.
Lomenick JP, Melguizo MS, Mitchell SL, Summar ML, Anderson JW (2009). Effects of meals high in carbohydrate, protein, and fat on ghrelin and peptide YY secretion in prepubertal children. J Clin Endocrinol Metab 94, 4463–4471.
Miyoshi K, Fuchimoto S, Ohsaki T, Sakata T, Ohtsuka S, Takakura N (2001). Long-term effects of jejunal pouch added to Roux-en-Y reconstruction after total gastrectomy. Gastric Cancer 4, 156–161.
Natalucci G, Riedl S, Gleiss A, Zidek T, Frisch H (2005). Spontaneous 24-h ghrelin secretion pattern in fasting subjects: maintenance of a meal-related pattern. Eur J Endocrinol 152, 845–850.
Pekic S, Pesko P, Djurovic M, Miljic D, Doknic M, Glodic J et al. (2006). Plasma ghrelin levels of gastrectomized and vagotomized patients are not affected by glucose administration. Clin Endocrinol (Oxf) 64, 684–688.
Pfluger PT, Kirchner H, Günnel S, Schrott B, Perez-Tilve D, Fu S et al. (2008). Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure. Am J Physiol Gastrointest Liver Physiol 294, G610–G618.
Schall R (1991). Estimation in generalized linear models with random effects. Biometrika 4, 719–727.
Schölmerich J (2004). Postgastrectomy syndromes--diagnosis and treatment. Best Pract Res Clin Gastroenterol 18, 917–933.
Stratis C, Alexandrides T, Vagenas K, Kalfarentzos F (2006). Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study. Obes Surg 16, 752–758.
Takachi K, Doki Y, Ishikawa O, Miyashiro I, Sasaki Y, Ohigashi H et al. (2006). Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy. J Surg Res 130, 1–7.
Takase M, Sumiyama Y, Nagao J (2003). Quantitative evaluation of reconstruction methods after gastrectomy using a new type of examination: digestion and absorption test with stable isotope 13C-labeled lipid compound. Gastric Cancer 6, 134–141.
Wang HT, Lu QC, Wang Q, Wang RC, Zhang Y, Chen HL et al. (2008). Role of the duodenum in regulation of plasma ghrelin levels and body mass index after subtotal gastrectomy. World J Gastroenterol 14, 2425–2429.
Weir JB (1949). New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109, 1–9.
Wren AM, Bloom SR (2007). Gut hormones and appetite control. Gastroenterology 132, 2116–2130.
Acknowledgements
This study was supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Kamiji, M., Troncon, L., Antunes-Rodrigues, J. et al. Ghrelin and PYY3−36 in gastrectomized and vagotomized patients: relations with appetite, energy intake and resting energy expenditure. Eur J Clin Nutr 64, 845–852 (2010). https://doi.org/10.1038/ejcn.2010.88
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2010.88
Keywords
This article is cited by
-
Impact of the Hepatic Branch of the Vagus Nerve Transection in Laparoscopic Sleeve Gastrectomy for Patients with Obesity and Type 2 Diabetes Mellitus
Obesity Surgery (2021)
-
Efficacy and safety of the “Xingnao Kaiqiao” acupuncture technique via intradermal needling to treat postoperative gastrointestinal dysfunction of laparoscopic surgery: study protocol for a randomized controlled trial
Trials (2017)